Explore the words cloud of the GLYCOVAX project. It provides you a very rough idea of what is the project "GLYCOVAX" about.
The following table provides information about the project.
Coordinator |
GLAXOSMITHKLINE VACCINES SRL
Organization address contact info |
Coordinator Country | Italy [IT] |
Project website | http://www.glycovax.eu |
Total cost | 3˙554˙499 € |
EC max contribution | 3˙554˙499 € (100%) |
Programme |
1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers) |
Code Call | H2020-MSCA-ITN-2015 |
Funding Scheme | MSCA-ITN-ETN |
Starting year | 2015 |
Duration (year-month-day) | from 2015-11-01 to 2019-10-31 |
Take a look of project's partnership.
GLYCOVAX is a network for the education of promising young scientists who will learn how to rationally design a next generation of well-defined and innovative glycoconjugate vaccines to improve current preventive therapies and to tackle unmet medical needs. Glycoconjugate vaccines represent the key for success of vaccination in children. The covalent linkage to proteins renders carbohydrates able to evoke a T-cell memory response. Current vaccines are prepared from heterogeneous mixtures of sugars linked by unspecific methods to the carrier protein giving complex mixtures of products. Due to this intricate structure, it has not been possible to apply a medicinal chemistry approach in the development of glycoconjugate vaccines and to fully understand their mechanism of action. Combination of novel approaches for glycan synthesis and site-selective conjugation methods now gives access to conjugates defined in sugar component and attachment site, thus leading to robust structure-immunogenicity relationship. Advancements in structural biophysics can be applied to select the optimal glycan antigen. By combining the beneficiaries’ expertise in carbohydrate synthesis, bioconjugation, high throughput screening, structural glycobiology, vaccinology and immunology, together with the experience in project management, GLYCOVAX will create a multidisciplinary environment where 14 young researchers will contribute to develop a novel route towards improved, safer and better characterized glycoconjugate vaccines, and contemporarily acquire transferable skills which will lead them to become the new leaders of academic or industrial research. The network will involve 9 academic groups and 2 industrial partners as Beneficiaries, and one SME as Partner Organization. The profound interaction between academy and industry will aid the students to get new concepts and visions for translating their ideas from the bench to the manufacturing of the next generation of glycoconjugate vaccines.
Local Training | Documents, reports | 2020-03-06 16:14:26 |
Glycoscience workshops | Documents, reports | 2020-02-12 17:16:50 |
Annual GLYCOVAX symposiums | Documents, reports | 2020-02-07 15:50:47 |
CTS | Documents, reports | 2020-02-07 15:50:47 |
Plan for using and disseminating knowledge | Websites, patent fillings, videos etc. | 2020-02-07 15:50:48 |
PhD | Documents, reports | 2020-02-07 15:50:44 |
Reports on public engagement activities | Documents, reports | 2020-02-07 15:50:49 |
Call publication | Other | 2019-09-06 08:53:52 |
Website | Websites, patent fillings, videos etc. | 2019-09-06 08:53:53 |
Take a look to the deliverables list in detail: detailed list of GLYCOVAX deliverables.
year | authors and title | journal | last update |
---|---|---|---|
2020 |
Roberto Adamo, Davide Oldrini, Linda del Bino, Ana Arda, Filippo Carboni, Pedro Henriques, Francesca Angiolini, Jon I. Quintana, Ilaria Calloni, Maria R. Romano, Francesco Berti, Jesus Jimenez Barbero, Immaculada Margarit Structureâ€guided design of a Group B Streptococcus type III synthetic glycanâ€conjugate vaccine published pages: , ISSN: 0947-6539, DOI: 10.1002/chem.202000284 |
Chemistry – A European Journal | 2020-03-10 |
2018 |
Cinzia Colombo, Olimpia Pitirollo, Luigi Lay Recent Advances in the Synthesis of Glycoconjugates for Vaccine Development published pages: 1712, ISSN: 1420-3049, DOI: 10.3390/molecules23071712 |
Molecules 23/7 | 2020-01-30 |
2019 |
F Romero-Saavedra, D Laverde, E Kalfopoulou, C Martini, R Torelli, D Martinez-Matamoros, M Sanguinetti, J Huebner Conjugation of Different Immunogenic Enterococcal Vaccine Target Antigens Leads to Extended Strain Coverage published pages: 1589-1598, ISSN: 0022-1899, DOI: 10.1093/infdis/jiz357 |
The Journal of Infectious Diseases 220/10 | 2019-11-07 |
2019 |
Ermioni Kalfopoulou, Diana Laverde, Karmela Miklic, Felipe Romero-Saavedra, Suzana Malic, Filippo Carboni, Roberto Adamo, Tihana Lenac Rovis, Stipan Jonjic, Johannes Huebner Development of Opsonic Mouse Monoclonal Antibodies against Multidrug-Resistant Enterococci published pages: , ISSN: 0019-9567, DOI: 10.1128/iai.00276-19 |
Infection and Immunity 87/9 | 2019-11-07 |
2018 |
Tetiana Dumych, Nao Yamakawa, Adeline Sivignon, Estelle Garenaux, Stefania Robakiewicz, Bernadette Coddeville, Antonino Bongiovanni, Fabrice Bray, Nicolas Barnich, Sabine Szunerits, Christian Slomianny, Martin Herrmann, Sébastien G. Gouin, Alexander D. Lutsyk, Luis E. Munoz, Frank Lafont, Christian Rolando, Rostyslav Bilyy, Julie M. J. Bouckaert Oligomannose-Rich Membranes of Dying Intestinal Epithelial Cells Promote Host Colonization by Adherent-Invasive E. coli published pages: , ISSN: 1664-302X, DOI: 10.3389/fmicb.2018.00742 |
Frontiers in Microbiology 9 | 2019-11-07 |
2019 |
Francesca Micoli, Linda Del Bino, Renzo Alfini, Filippo Carboni, Maria Rosaria Romano, Roberto Adamo Glycoconjugate vaccines: current approaches towards faster vaccine design published pages: 881-895, ISSN: 1476-0584, DOI: 10.1080/14760584.2019.1657012 |
Expert Review of Vaccines 18/9 | 2019-11-07 |
2018 |
Claudia Kohout, Cristina Santi, Laura Polito Anisotropic Gold Nanoparticles in Biomedical Applications published pages: 3385, ISSN: 1422-0067, DOI: 10.3390/ijms19113385 |
International Journal of Molecular Sciences 19/11 | 2019-11-07 |
2018 |
Daan van der Es, Francesca Berni, Wouter F. J. Hogendorf, Nico Meeuwenoord, Diana Laverde, Angela van Diepen, Herman S. Overkleeft, Dmitri V. Filippov, Cornelis H. Hokke, Johannes Huebner, Gijsbert A. van der Marel, Jeroen D. C. Codée Streamlined Synthesis and Evaluation of Teichoic Acid Fragments published pages: 4014-4018, ISSN: 0947-6539, DOI: 10.1002/chem.201800153 |
Chemistry - A European Journal 24/16 | 2019-09-06 |
2018 |
Ilaria Calloni, Luca Unione, Gonzalo Jiménez-Osés, Francisco Corzana, Linda Del Bino, Alessio Corrado, Olimpia Pitirollo, Cinzia Colombo, Luigi Lay, Roberto Adamo, Jesús Jiménez-Barbero The Conformation of the Mannopyranosyl Phosphate Repeating Unit of the Capsular Polysaccharide of Neisseria meningitidis Serogroup A and Its Carba-Mimetic published pages: 4548-4555, ISSN: 1434-193X, DOI: 10.1002/ejoc.201801003 |
European Journal of Organic Chemistry 2018/33 | 2019-09-06 |
2018 |
Francesco Berti, Roberto Adamo Antimicrobial glycoconjugate vaccines: an overview of classic and modern approaches for protein modification published pages: , ISSN: 0306-0012, DOI: 10.1039/c8cs00495a |
Chemical Society Reviews | 2019-09-06 |
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "GLYCOVAX" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "GLYCOVAX" are provided by the European Opendata Portal: CORDIS opendata.